SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-24-033273
Filing Date
2024-02-13
Accepted
2024-02-13 12:36:57
Documents
2
Group Members
ALBERT CHADANIEL ESTESFHMLS XI, L.L.C.FHMLS XI, L.P.FHMLSP OVERAGE, L.L.C.FHMLSP OVERAGE, L.P.FHMLSP, L.L.C.FHMLSP, L.P.FRAZIER LIFE SCIENCES PUBLIC OVERAGE FUND, L.P.FRAZIER LIFE SCIENCES XI, L.P.JAMES BRUSHJAMES N. TOPPERPATRICK J. HERON

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d778296dsc13ga.htm SC 13G/A 222303
2 EX-99.A d778296dex99a.htm EX-99.A 23194
  Complete submission text file 0001193125-24-033273.txt   247579
Mailing Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142
Business Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Subject) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92944 | Film No.: 24624019
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1001 PAGE MILL ROAD BUILDING 4, SUITE B PALO ALTO CA 94304
Business Address 1001 PAGE MILL ROAD BUILDING 4, SUITE B PALO ALTO CA 94304 650-325-5156
Frazier Life Sciences Public Fund, L.P. (Filed by) CIK: 0001863769 (see all company filings)

IRS No.: 862999645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A